NCT03297281 - Stop or Ongoing Oral Anticoagulation in Patients Undergoing Pvp (SOAP) | Biotech Hunter

Enrollment

389

Participants

Timeline

Start Date

October 30, 2017

Primary Completion Date

November 30, 2025

Study Completion Date

May 31, 2026

Conditions

Benign Prostatic HyperplasiaAnticoagulant Adverse Reaction

Interventions

OTHER

Maintenance of OAC in surgery of BPH by PVP.

The maintenance of AVK or DOACs treatment in the perioperative setting (without interruption of oral treatment).

OTHER

Discontinuation of OAC in surgery of BPH by PVP.

The discontinuation of AVK or DOACs treatment with perioperative heparin relay during postoperative course.

Trial Locations (1)

RECRUITING

Clinique Pasteur, Toulouse